BlackRock’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-430
Closed -$5K 3232
2014
Q3
$5K Hold
430
﹤0.01% 3110
2014
Q2
$7K Buy
+430
New +$6.4K ﹤0.01% 3046

BlackRock's DRTX Position: Q4 2014 in Review

BlackRock sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 430 shares — an estimated $5K sold.

BlackRock first reported a position in DRTX in Q2 2014 and held it in 2 quarters. The position peaked at $7K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • BlackRock reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • BlackRock sold 430 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $5K.
  • BlackRock first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • BlackRock's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $7K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on BlackRock's 13F filing for Q4 2014, filed 9 Feb 2015.